Cargando…

Electroporation as the Immunotherapy Strategy for Cancer in Veterinary Medicine: State of the Art in Latin America

Electroporation is a technology that increases cell membrane permeability by the application of electric pulses. Electrochemotherapy (ECT), the best-known application of electroporation, is a very effective local treatment for tumors of any histology in human and veterinary medicine. It induces a lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Maglietti, Felipe, Tellado, Matías, De Robertis, Mariangela, Michinski, Sebastián, Fernández, Juan, Signori, Emanuela, Marshall, Guillermo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564659/
https://www.ncbi.nlm.nih.gov/pubmed/32957424
http://dx.doi.org/10.3390/vaccines8030537
_version_ 1783595765572042752
author Maglietti, Felipe
Tellado, Matías
De Robertis, Mariangela
Michinski, Sebastián
Fernández, Juan
Signori, Emanuela
Marshall, Guillermo
author_facet Maglietti, Felipe
Tellado, Matías
De Robertis, Mariangela
Michinski, Sebastián
Fernández, Juan
Signori, Emanuela
Marshall, Guillermo
author_sort Maglietti, Felipe
collection PubMed
description Electroporation is a technology that increases cell membrane permeability by the application of electric pulses. Electrochemotherapy (ECT), the best-known application of electroporation, is a very effective local treatment for tumors of any histology in human and veterinary medicine. It induces a local yet robust immune response that is responsible for its high effectiveness. Gene electrotransfer (GET), used in research to produce a systemic immune response against cancer, is another electroporation-based treatment that is very appealing for its effectiveness, low cost, and simplicity. In this review, we present the immune effect of electroporation-based treatments and analyze the results of the vast majority of the published papers related to immune response enhancement by gene electrotransfer in companion animals with spontaneous tumors. In addition, we present a brief history of the initial steps and the state of the art of the electroporation-based treatments in Latin America. They have the potential to become an essential form of immunotherapy in the region. This review gives insight into the subject and helps to choose promising research lines for future work; it also helps to select the adequate treatment parameters for performing a successful application of this technology.
format Online
Article
Text
id pubmed-7564659
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75646592020-10-29 Electroporation as the Immunotherapy Strategy for Cancer in Veterinary Medicine: State of the Art in Latin America Maglietti, Felipe Tellado, Matías De Robertis, Mariangela Michinski, Sebastián Fernández, Juan Signori, Emanuela Marshall, Guillermo Vaccines (Basel) Review Electroporation is a technology that increases cell membrane permeability by the application of electric pulses. Electrochemotherapy (ECT), the best-known application of electroporation, is a very effective local treatment for tumors of any histology in human and veterinary medicine. It induces a local yet robust immune response that is responsible for its high effectiveness. Gene electrotransfer (GET), used in research to produce a systemic immune response against cancer, is another electroporation-based treatment that is very appealing for its effectiveness, low cost, and simplicity. In this review, we present the immune effect of electroporation-based treatments and analyze the results of the vast majority of the published papers related to immune response enhancement by gene electrotransfer in companion animals with spontaneous tumors. In addition, we present a brief history of the initial steps and the state of the art of the electroporation-based treatments in Latin America. They have the potential to become an essential form of immunotherapy in the region. This review gives insight into the subject and helps to choose promising research lines for future work; it also helps to select the adequate treatment parameters for performing a successful application of this technology. MDPI 2020-09-17 /pmc/articles/PMC7564659/ /pubmed/32957424 http://dx.doi.org/10.3390/vaccines8030537 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Maglietti, Felipe
Tellado, Matías
De Robertis, Mariangela
Michinski, Sebastián
Fernández, Juan
Signori, Emanuela
Marshall, Guillermo
Electroporation as the Immunotherapy Strategy for Cancer in Veterinary Medicine: State of the Art in Latin America
title Electroporation as the Immunotherapy Strategy for Cancer in Veterinary Medicine: State of the Art in Latin America
title_full Electroporation as the Immunotherapy Strategy for Cancer in Veterinary Medicine: State of the Art in Latin America
title_fullStr Electroporation as the Immunotherapy Strategy for Cancer in Veterinary Medicine: State of the Art in Latin America
title_full_unstemmed Electroporation as the Immunotherapy Strategy for Cancer in Veterinary Medicine: State of the Art in Latin America
title_short Electroporation as the Immunotherapy Strategy for Cancer in Veterinary Medicine: State of the Art in Latin America
title_sort electroporation as the immunotherapy strategy for cancer in veterinary medicine: state of the art in latin america
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564659/
https://www.ncbi.nlm.nih.gov/pubmed/32957424
http://dx.doi.org/10.3390/vaccines8030537
work_keys_str_mv AT magliettifelipe electroporationastheimmunotherapystrategyforcancerinveterinarymedicinestateoftheartinlatinamerica
AT telladomatias electroporationastheimmunotherapystrategyforcancerinveterinarymedicinestateoftheartinlatinamerica
AT derobertismariangela electroporationastheimmunotherapystrategyforcancerinveterinarymedicinestateoftheartinlatinamerica
AT michinskisebastian electroporationastheimmunotherapystrategyforcancerinveterinarymedicinestateoftheartinlatinamerica
AT fernandezjuan electroporationastheimmunotherapystrategyforcancerinveterinarymedicinestateoftheartinlatinamerica
AT signoriemanuela electroporationastheimmunotherapystrategyforcancerinveterinarymedicinestateoftheartinlatinamerica
AT marshallguillermo electroporationastheimmunotherapystrategyforcancerinveterinarymedicinestateoftheartinlatinamerica